Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 291

1.

Genetic testing for hereditary cancers: the impact of gender on interest, uptake and ethical considerations.

d'Agincourt-Canning L, Baird P.

Crit Rev Oncol Hematol. 2006 May;58(2):114-23. Epub 2006 Apr 4. Review.

PMID:
16600617
[PubMed - indexed for MEDLINE]
2.

Development and pilot testing of two decision aids for individuals considering genetic testing for cancer risk.

Wakefield CE, Meiser B, Homewood J, Peate M, Kirk J, Warner B, Lobb E, Gaff C, Tucker K.

J Genet Couns. 2007 Jun;16(3):325-39. Epub 2007 Feb 23.

PMID:
17318456
[PubMed - indexed for MEDLINE]
3.

Risk assessment and genetic counseling for hereditary breast and ovarian cancer: recommendations of the National Society of Genetic Counselors.

Berliner JL, Fay AM; Practice Issues Subcommittee of the National Society of Genetic Counselors' Familial Cancer Risk Counseling Special Interest Group.

J Genet Couns. 2007 Jun;16(3):241-60. Epub 2007 May 17. Review.

PMID:
17508274
[PubMed - indexed for MEDLINE]
4.

Genetic counseling, testing, and screening for breast and ovarian cancer: practical and social considerations.

Khabele D, Runowicz CD.

Curr Womens Health Rep. 2002 Jun;2(3):163-9. Review.

PMID:
12099190
[PubMed - indexed for MEDLINE]
5.

Cancer genetics in primary care.

Culler D, Grimes SJ, Acheson LS, Wiesner GL.

Prim Care. 2004 Sep;31(3):649-83, xi. Review.

PMID:
15331253
[PubMed - indexed for MEDLINE]
6.

Genetic testing for breast and ovarian cancer susceptibility: a family experience.

Van Riper M, McKinnon WC.

J Midwifery Womens Health. 2004 May-Jun;49(3):210-9. Review.

PMID:
15134674
[PubMed - indexed for MEDLINE]
7.

Inequality of use of cancer genetics services by members of breast, ovarian and colorectal cancer families in South East Scotland.

Holloway SM, Bernhard B, Campbell H, Cetnarskyj R, Lam WW.

Fam Cancer. 2008;7(3):259-64. doi: 10.1007/s10689-008-9184-x. Epub 2008 Feb 2.

PMID:
18246448
[PubMed - indexed for MEDLINE]
8.

Genetic testing for breast and ovarian cancer: ethical, legal, and psychosocial considerations.

Lessick M.

Nurs Womens Health. 2007 Aug;11(4):390-9; quiz 400-1. No abstract available.

PMID:
17883756
[PubMed - indexed for MEDLINE]
9.

Cancer risk assessment and the genetic counseling process: using hereditary breast and ovarian cancer as an example.

Prucka SK, McIlvried DE, Korf BR.

Med Princ Pract. 2008;17(3):173-89. doi: 10.1159/000117790. Epub 2008 Apr 10. Review.

PMID:
18408385
[PubMed - indexed for MEDLINE]
10.

Psychological impact of genetic testing for cancer susceptibility: an update of the literature.

Meiser B.

Psychooncology. 2005 Dec;14(12):1060-74. Review.

PMID:
15937976
[PubMed - indexed for MEDLINE]
11.

Psychosocial and behavioral impact of genetic counseling and testing.

Vadaparampil ST, Miree CA, Wilson C, Jacobsen PB.

Breast Dis. 2006-2007;27:97-108. Review.

PMID:
17917142
[PubMed - indexed for MEDLINE]
12.

Influence of race/ethnicity on genetic counseling and testing for hereditary breast and ovarian cancer.

Forman AD, Hall MJ.

Breast J. 2009 Sep-Oct;15 Suppl 1:S56-62. doi: 10.1111/j.1524-4741.2009.00798.x. Review.

PMID:
19775331
[PubMed - indexed for MEDLINE]
13.

Genetic and familial factors influencing breast, colon, prostate and lung cancers.

Stein QP, Flanagan JD.

S D Med. 2010;Spec No:16-22. Review.

PMID:
20397487
[PubMed - indexed for MEDLINE]
14.

Attitudes toward genetic testing for cancer risk after genetic counseling and decision support: a qualitative comparison between hereditary cancer types.

Wakefield CE, Kasparian NA, Meiser B, Homewood J, Kirk J, Tucker K.

Genet Test. 2007 Winter;11(4):401-11. doi: 10.1089/gte.2007.0013.

PMID:
18294057
[PubMed - indexed for MEDLINE]
15.

Ethical implications of predictive DNA testing for hereditary breast cancer.

Di Pietro ML, Giuli A, Spagnolo AG.

Ann Oncol. 2004;15 Suppl 1:I65-I70.

PMID:
15280191
[PubMed - indexed for MEDLINE]
Free Article
16.

Genetic services for hereditary breast/ovarian and colorectal cancers - physicians' awareness, use and satisfaction.

Carroll JC, Cappelli M, Miller F, Wilson BJ, Grunfeld E, Peeters C, Hunter AG, Gilpin C, Prakash P.

Community Genet. 2008;11(1):43-51. doi: 10.1159/000111639. Epub 2008 Jan 15.

PMID:
18196917
[PubMed - indexed for MEDLINE]
17.

Factors associated with an individual's decision to withdraw from genetic testing for breast and ovarian cancer susceptibility: implications for counseling.

Godard B, Pratte A, Dumont M, Simard-Lebrun A, Simard J.

Genet Test. 2007 Spring;11(1):45-54.

PMID:
17394392
[PubMed - indexed for MEDLINE]
18.

Hereditary breast-ovarian cancer: clinical findings and medical management.

Marshall M, Solomon S.

Plast Surg Nurs. 2007 Jul-Sep;27(3):124-7. Review.

PMID:
17901820
[PubMed - indexed for MEDLINE]
19.

Hereditary breast and ovarian cancer syndrome : the impact of race on uptake of genetic counseling and testing.

Simon MS, Petrucelli N.

Methods Mol Biol. 2009;471:487-500. doi: 10.1007/978-1-59745-416-2_25.

PMID:
19109796
[PubMed - indexed for MEDLINE]
20.

[Social and family considerations in genetic counselling].

Svendsen MN, Koch L.

Ugeskr Laeger. 2006 Jun 12;168(24):2348-50. Danish.

PMID:
16822418
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk